Pineapple gel approved for burns


A topical gel based on pineapple enzymes has been approved in the EU for use in the treatment of burns.

NexoBrid gel from privately owned biotech MediWound, contains proteolytic enzymes from the stem of the pineapple plant. It is the first pharmacological treatment for the removal of scab tissue associated with severe burns, which are typically removed surgically. Removal of scab tissue is essential to speed the healing process and prevent infection.

NexoBrid gel was designated an orphan medicine in 2002. Israeli generics giants Teva paid $163 million to raise its stake in Mediwound from 14% to 51% in 2010, according to Reuters.


Related Content

Myelofibrosis drug approved in EU

28 August 2012 Business

news image

Jakavi (ruxolitinib) tablets are for the treatment of myelofibrosis, a rare disease affecting the bone marrow

New EU law set to open door to GM crops

15 January 2015 News and Analysis

news image

Legislation that will let member states ban GMOs expected to ease approval of GM crops by Europe

Most Read

Self-cleaning sensors see the light

23 January 2015 Research

news image

Overcoming electrode fouling in biomedical and environmental detectors

Alkali metal explosion explained

26 January 2015 Research

news image

High-speed cameras help re-examine the chemistry behind a classic classroom demonstration

Most Commented

Alkali metal explosion explained

26 January 2015 Research

news image

High-speed cameras help re-examine the chemistry behind a classic classroom demonstration

What we mean when we talk about bonds

29 January 2015 Comments

news image

Santiago Alvarez delves into the debates and disagreements that surround one of chemistry's most fundamental concepts